We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 36 results
  1. The disulfide bond Cys2724-Cys2774 in the C-terminal cystine knot domain of von Willebrand factor is critical for its dimerization and secretion

    Background

    Type 3 von Willebrand disease (VWD) exhibits severe hemorrhagic tendency with complicated pathogenesis. The C-terminal cystine knot (CTCK)...

    Yuxin Zhang, Fengwu Chen, ... **gyu Zhang in Thrombosis Journal
    Article Open access 27 November 2021
  2. Von Willebrand Factor and Platelet Aggregation: from Bench to Clinical Practice

    Purpose of Review

    This review describes von Willebrand factor (VWF)-mediated platelet function in inherited and acquired bleeding disorders, and...

    Katrina J. Ashworth, Kimberly A. Thomas, Susan M. Shea in Current Anesthesiology Reports
    Article 21 March 2022
  3. Molecular and clinical profile of type 2 von Willebrand disease in Iran: a thirteen-year experience

    Type 2 von Willebrand disease (VWD) is the most common congenital bleeding disorder, with variable bleeding tendency and a complex laboratory...

    Maryam Rassoulzadegan, Fereydoun Ala, ... Akbar Dorgalaleh in International Journal of Hematology
    Article 14 January 2020
  4. Vwf K1362A resulted in failure of protein synthesis in mice

    Von Willebrand factor (VWF) is synthesized in megakaryocytes and endothelial cells (ECs) and has two main roles: to carry and protect coagulation...

    Naomi Sanda, Nobuaki Suzuki, ... Shigeo Nakamura in International Journal of Hematology
    Article 01 February 2018
  5. Emerging new therapeutic antibody derivatives for cancer treatment

    Monoclonal antibodies constitute a promising class of targeted anticancer agents that enhance natural immune system functions to suppress cancer cell...

    Shijie **, Yan** Sun, ... Liqiang Pan in Signal Transduction and Targeted Therapy
    Article Open access 07 February 2022
  6. The role of von Willebrand factor in thrombotic microangiopathy

    Thrombotic microangiopathy (TMA) is caused by thrombus formation in the microvasculature. The disease spectrum of TMA includes, amongst others,...

    Damien G. Noone, Magdalena Riedl, Christoph Licht in Pediatric Nephrology
    Article 26 July 2017
  7. Gastrointestinal Bleeding in Native and Prosthetic Valve Disease

    Gastrointestinal bleeding with severe aortic stenosis was originally described in the 1950s by Heyde, although for years, the association was...

    Article 01 January 2018
  8. Thrombotic thrombocytopenic purpura

    Thrombotic thrombocytopenic purpura (TTP; also known as Moschcowitz disease) is characterized by the concomitant occurrence of often severe...

    Johanna A. Kremer Hovinga, Paul Coppo, ... Karen Vanhoorelbeke in Nature Reviews Disease Primers
    Article 06 April 2017
  9. Mutations in the D1 domain of von Willebrand factor impair their propeptide-dependent multimerization, intracellular trafficking and secretion

    We identified three novel mutations (p.Gly39Arg, p.Lys157Glu, p.Cys379Gly) and one previously known mutation (p.Asp141Asn) in the von Willebrand...

    Jie Yin, Zhenni Ma, ... Changgeng Ruan in Journal of Hematology & Oncology
    Article Open access 20 June 2015
  10. A new ER-specific photosensitizer unravels 1O2-driven protein oxidation and inhibition of deubiquitinases as a generic mechanism for cancer PDT

    Photosensitizers (PS) are ideally devoid of any activity in the absence of photoactivation, and rely on molecular oxygen for the formation of singlet...

    A Pinto, Y Mace, ... O Feron in Oncogene
    Article 21 December 2015
  11. Von Willebrand Disease: Range of the Disease, and Management

    Von Willebrand disease is the most common autosomal inherited bleeding disorder. It is caused by quantitative or qualitative defects of the von...

    Karen S. Fernández, Pedro A. de Alarcón in Current Pediatrics Reports
    Article 30 November 2013
  12. The unfolded von Willebrand factor response in bloodstream: the self-association perspective

    von Willebrand factor (vWF) is a multimeric glycoprotein essential for hemostasis after vascular injury, which modulates platelet-surface and...

    Hailong Yuan, Ning Deng, ... Qing Zhang in Journal of Hematology & Oncology
    Article Open access 15 October 2012
  13. Elevated Von Willebrand factor propeptide for the diagnosis of thrombotic microangiopathy and for predicting a poor outcome

    Thrombotic microangiopathy (TMA) is associated with vascular endothelial cell injury and is sometimes linked with poor outcome. Von Willebrand factor...

    Naomi Ito-Habe, Hideo Wada, ... Naoyuki Katayama in International Journal of Hematology
    Article 09 December 2010
  14. Characterization of antibodies for quantitative determination of spiggin protein levels in male and female three-spined stickleback (Gasterosteus aculeatus)

    Spiggin is an adhesive glycoprotein produced in the kidney of sticklebacks during the breeding season and is subsequently secreted into the urinary...

    Håkan Berg, Nikolai Scherbak, ... Per-Erik Olsson in Reproductive Biology and Endocrinology
    Article Open access 14 May 2009
  15. von Willebrand factor in CHD and stroke: Relationships and therapeutic implications

    Atherosclerotic cardiovascular disease (CVD), which includes coronary heart disease (CHD) and stroke, is now the most common cause of death in the...

    Marie-Therese Cooney, Alexandra L. Dudina, ... Ian M. Graham in Current Treatment Options in Cardiovascular Medicine
    Article 18 May 2007
  16. The effects of colloid solutions on hemostasis

    Purpose

    Colloid solutions are widely used to prevent or to correct hypovolemia in surgical patients. Although more efficacious than crystalloids, they...

    Philippe Van der Linden, Brigitte E. Ickx in Canadian Journal of Anesthesia
    Article 01 June 2006
  17. New Insight into the Molecular Basis of Hemophilia A

    Since publication of the sequence of the factor VIII gene ( F8 ) in 1984, a large number of mutations that cause hemophilia A (HA) have been...

    Johannes Oldenburg, Osman El-Maarri in International Journal of Hematology
    Article 01 February 2006
Did you find what you were looking for? Share feedback.